三鑫医疗股价涨5.07%，汇安基金旗下1只基金重仓，持有11.71万股浮盈赚取5.86万元

Core Viewpoint - Sanxin Medical has shown a positive stock performance with a 5.07% increase, reaching a price of 10.36 CNY per share, and a total market capitalization of 5.409 billion CNY [1] Company Overview - Sanxin Medical Technology Co., Ltd. is located in Nanchang, Jiangxi Province, and was established on March 7, 1997, with its listing date on May 15, 2015 [1] - The company's main business involves the research, manufacturing, sales, and service of medical devices [1] - Revenue composition is as follows: blood purification products account for 82.23%, drug delivery devices for 10.83%, cardiothoracic surgery products for 4.60%, and other categories for 2.34% [1] Fund Holdings - Huian Fund has a significant holding in Sanxin Medical, with its Huian Asset Rotation Mixed A Fund (005360) being the largest shareholder [2] - In the third quarter, the fund reduced its holdings by 36,300 shares, maintaining a total of 117,100 shares, which represents 9.2% of the fund's net value [2] - The fund has achieved a year-to-date return of 10.07%, ranking 5958 out of 8147 in its category [2]